文献速递传染病防控与疫情报告免疫规划

健康成人对呼吸道合胞病毒融合蛋白p27肽的抗体应答

Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein.
PubMed 文献 · Vaccine · 2021-12-10

研究纳入2018-2019年休斯顿19名65岁以下健康成人,评估自然RSV再感染后血清p27肽抗体应答动态。抗p27抗体在所有受试者各次访视均可检出;急性感染组感染后显著升高,未感染组稳定,近期感染组下降。各访视对RSV/B p27抗体应答比对RSV/A低1.4-1.5倍,尽管为RSV/B优势暴发。

要点

  • 抗p27抗体在所有受试者各次访视均可检出。
  • 急性感染组RSV感染后抗p27抗体显著升高,未感染组稳定,近期感染组下降。
  • 各访视对RSV/B p27抗体应答较RSV/A低1.4-1.5倍。

核心结论

  • 自然RSV再感染后可产生针对F蛋白p27区域的抗体,提示部分F蛋白可能以部分切割状态存在于病毒颗粒表面。
  • 各访视对RSV/B p27的抗体应答较RSV/A低1.4-1.5倍,尽管为RSV/B优势暴发。

研究设计与样本

  • 2018-2019年RSV季节在休斯顿纳入19名65岁以下健康成人。
  • 三次研究访视采血,按中和抗体变化定义感染状态分为未感染组(n=12)、急性感染组(n=4)和近期感染组(n=3)。
  • 用酶联免疫吸附试验测血清抗RSV/A和RSV/B p27肽IgG与IgA抗体,用p27竞争抗体试验检测血清p27样抗体。

主要发现

  • 抗p27抗体在所有受试者各次访视均可检出。
  • 未感染组研究期间应答稳定,急性感染组RSV感染后显著升高,近期感染组研究期间抗p27抗体下降。
  • 各访视对RSV/B p27的抗体应答较RSV/A低1.4-1.5倍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The respiratory syncytial virus (RSV) fusion (F) protein undergoes two furin-cleavage events to become fusion competent, resulting in the release of a twenty-seven amino acid peptide (p27). Recent studies indicate that the p27 region of the F protein was an immunodominant antigen in young children. In this study, we evaluated the kinetics of the serum antibody response to the p27 peptide following natural RSV reinfection in adults. Nineteen healthy adults under sixty-five years of age were enrolled during the 2018-2019 RSV season in Houston, TX. Blood was collected at three study visits and RSV infection status was defined by changes in neutralizing antibody resulting in three groups: uninfected (n = 12), acutely infected (n = 4), and recently infected (n = 3). Serum IgG and IgA antibodies against RSV/A and RSV/B p27 peptides were measured by enzyme-linked immunosorbent assays, and serum p27-like antibodies were detected by a p27 competitive antibody assay. Anti-p27 antibodies were detected in all subjects at each study visit. The measured IgG and IgA anti-p27 antibody levels followed the same pattern as other RSV site-specific and neutralizing antibody responses described for this cohort previously: the uninfected group had stable responses for the duration of the study period, the acutely infected group had a significant increase following RSV infection, and the recently infected group had a decrease in anti-p27 antibody during the study period. These results indicate that antibodies to the p27 region of the F protein are generated following natural RSV reinfection and suggest that some of the F protein is potentially in a partially cleaved state on the surface of virions, expanding on the previous assumption that all of p27 is post-translationally released and not present on mature F. Additionally, antibody responses were significantly lower (1.4-1.5-fold) toward RSV/B than to RSV/A p27 at each study visit, despite being an RSV/B dominant outbreak. Understanding the mechanism for the differences in the magnitude of the RSV/A and RSV/B p27 antibody response may enhance our understanding of the intracellular processing of the F protein.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Blunck BN, Aideyan L, Ye X, et al. Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein. Vaccine. 2021. PMID: 34903371. doi:10.1016/j.vaccine.2021.11.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。